Evidence map›Paper›PMID 40380768›Full record

ArticleBiophysical journal2025

Measuring PARP1 mobility at DNA damage sites by segmented fluorescence correlation spectroscopy.

Elisa Longo, Greta Paternò, Alberto Diaspro, Luca Lanzanò

Abstract read
In one paragraph

Article in Biophysical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elisa LongoDepartment of Physics and Astronomy "Ettore Majorana", University of Catania, Catania, Italy.
Greta PaternòDepartment of Physics and Astronomy "Ettore Majorana", University of Catania, Catania, Italy.
Alberto DiasproNanoscopy, CHT Erzelli, Istituto Italiano di Tecnologia, Genoa, Italy; DIFILAB, Department of Physics, University of Genoa, Genoa, Italy.
Luca LanzanòDepartment of Physics and Astronomy "Ettore Majorana", University of Catania, Catania, Italy; Nanoscopy, CHT Erzelli, Istituto Italiano di Tecnologia, Genoa, Italy; Istituto Nazionale di Fisica Nucleare (INFN), Sezione di Catania, Catania, Italy; Centro Siciliano di Fisica Nucleare e Struttura della Materia (CSFNSM), Catania, Italy. Electronic address: luca.lanzano@unict.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Segmented fluorescence correlation spectroscopy (FCS) improves the accuracy of FCS measurements in cells by analyzing data in short temporal segments. We have recently demonstrated the possibility of performing segmented FCS using a commercial confocal laser scanning microscope, enabling the measurement of molecular diffusion in different subcellular regions. In this study, we apply segmented FCS to investigate the dynamics of poly(ADP-ribose) polymerase 1 (PARP1), a protein that plays a central role in the DNA damage response. We perform fast line scanning across the nucleoplasm of live cells to measure the recruitment kinetics of PARP1 at DNA damage sites after laser micro-irradiation. The segmentation of FCS data allows us to distinguish between the damaged and undamaged regions and to measure the mobility of PARP1 in the two regions. We find reduced mobility of PARP1 at DNA damage sites, described as the appearance of a binding fraction, whereas the diffusion of PARP1 is unaltered outside the DNA damage region. Additionally, we investigate the effect of photobleaching on the measured dynamics.

Indexed as

DNA DamagePoly(ADP-ribose) PolymerasesDiffusionHeLa CellsHumansKineticsPhotobleachingPoly (ADP-Ribose) Polymerase-1Protein TransportSpectrometry, FluorescencePARP1 protein, humanPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerases

Identifiers

PMID40380768
PMCPMC12709243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.